EMPOWER
DO YOU HAVE OR ARE YOU A PATIENT WITH HYPEREMESIS GRAVIDARUM?
You or they may be eligible for inclusion in a new study that UKTIS are currently involved in.
The EMPOWER (EMesis in Pregnancy – Ondansetron With mEtoclopRamide) study, funded by the NIHR, aims to determine the best treatment of Hypermesis Gravidarum.
It will also investigate the impact on participant’s quality of life and carry out a health economic analysis.
For more information please visit the EMPOWER website (https://sites.google.com/nihr.ac.uk/pregnancysickness-research/home).
Twitter: @EmpowerStudy
Facebook: The Empower Study